|
Volume: 26S1 - February 2000
Guidelines for Reporting Adverse Events Associated
with Vaccine Products
Supplementary guidelines for the Canadian Pharmaceutical Industry
Appendix 5 - Vaccine Associated Adverse Events
Reporting
[Previous]
[Table of Contents]
|
